Biogen Explains How Its Alzheimer’s Drug Went From Poor to Promising
news via Health – TIME
Biogen provided the first in-depth look at data behind its Alzheimer’s drug aducanumab, and experts are cautiously optimistic...
READ FULL ARTICLE »
Become a member to take advantage of more features, like commenting and voting.
Register or sign in today!